Drug interactions between rituximab and Zevalin
Interactions between your drugs
- Rituximab is in the following drug classes: antirheumatics, CD20 monoclonal antibodies.
- Rituximab is used to treat the following conditions:
- Bullous Pemphigoid
- Chronic Lymphocytic Leukemia
- Diffuse Large B-Cell Lymphoma
- Evan's Syndrome
- Focal Segmental Glomerulosclerosis
- Follicular Lymphoma
- Idiopathic Thrombocytopenic Purpura
- Mantle Cell Lymphoma
- Microscopic polyangiitis
- Non-Hodgkin's Lymphoma
- Rheumatoid Arthritis
- Wegener's Granulomatosis
- Zevalin is a member of the following drug classes: CD20 monoclonal antibodies, radiologic conjugating agents.
- Zevalin is used to treat Non-Hodgkin's Lymphoma.
Drug and food interactions
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
CD20 monoclonal antibodies
The recommended maximum number of medicines in the 'CD20 monoclonal antibodies' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'CD20 monoclonal antibodies' category:
- ibritumomab (active ingredient in Zevalin (ibritumomab))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.